Rare Diseases Equipment For Clinical Medicine
-
PremiumManufactured by membraPure GmbHbased in GERMANY
The Amino Acid Analyzer ARACUS IVD is available in two configurations: the ARACUS IVD Classic and the ARACUS IVD Advanced. This choice depends on whether the customer prefers a single-pump or a dual-pump ...
-
Manufactured by H. Buschkühl GmbHbased in GERMANY
The treatment of Lyme disease with photons, avoiding antibiotics at the same time, is a standard therapy in many practices today. During a period of three years, 108 persons were treated under control in an observational study. The relapse rate amounts less than 5%, not excluding cases of reinfection. We have successfully treated far over 1000 patients within nine years. This means, the patients ...
-
based in USA
QTORIN™ rapamycin 3.9% is a novel targeted topical therapy being studied for Microcystic Lymphatic Malformations (Micro LM). Palvella is enrolling a phase 2 clinical study for people with Micro ...
-
Manufactured by Caladrius Biosciences, Inc.based in USA
Also known as Chronic Limb-Threatening Ischemia (CLTI). Critical limb ischemia (CLI) is an advanced form of peripheral arterial disease (PAD) caused by a severe blockage in the arteries of the lower extremities. PAD is caused by atherosclerosis, the hardening and narrowing of the arteries over time due to the buildup of fatty deposits called plaque. CLI is a chronic condition that results in ...
-
based in USA
NuMedii has been pioneering the use of Big Data, Artificial Intelligence (AI) and systems biology since 2010 to accelerate the discovery of precision therapies to address high unmet medical needs. ...
-
Manufactured by GenoSensor Corporationbased in USA
GenoExplorer gene expression microarray is a high quality, completely customizable microarray that provides a cost effective and timely solution for microarray users. Oligonucleotide probes can be defined and designed by the user and supported by our bioinformatics and technical ...
-
Manufactured by Bausch Health Companies Inc.based in CANADA
Our diversified portfolio of well-established specialty pharmaceuticals targets several therapeutic areas, including epilepsy, migraines, depression, chronic pain, and rare diseases such as Huntington's disease. ...
-
Distributed by Salehiyah Establishmentbased in SAUDI ARABIA
Explore our diversified portfolio of pharmaceuticals, as we deliver the right medication to the right patient at the right time, covering some of the most critical needs of patients in the Kingdom. ...
-
Manufactured by SFA Therapeutics, Inc.based in USA
SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease – the use of microbiome-derived metabolites as ...
-
by Healx Ltd.based in UNITED KINGDOM
The world’s most efficient AI platform for rare disease drug discovery, supporting our teams and partners in our mission to advance new treatments towards the ...
-
Manufactured by Applied Pharma Research s.a.based in SWITZERLAND
GOLIKE PURE 3+ is a Food for Special Medical Purposes in granules for oral use consisting of a prolonged-released amino-acid mixture without phenylalanine, with carnitine and taurine. It is gluten and lactose free. ...
-
Manufactured by Catalent, Incbased in USA
Gene therapy holds the promise of treating the unmet needs of patients who suffer from a rare genetic disease. An estimated 4,000 medical conditions are a result of gene disorders with no previous targeted treatments. Gene therapy offers new options away from the conventional symptomatic approach to disease treatment as well as provides hope for real cures. At Catalent, we understand the unique ...
-
Manufactured by Worthington Biochemical Corporationbased in USA
Two times crystallized. A suspension in 2.4M ammonium sulfate containing 3% pyrophosphate and 0.1% glycine. Store at ...
-
Manufactured by Evox Therapeutics Limitedbased in UNITED KINGDOM
Phenylketonuria, or PKU, is an autosomal recessive inborn error of phenylalanine metabolism resulting in a deficiency of the hepatic enzyme phenylalanine hydroxylase ...
-
based in USA
Mucopolysaccharidosis type 1 (MPS 1) is a rare lysosomal storage disease that is caused by mutations in IDUA, the gene that encodes the alpha-L-iduronidase (IDUA) enzyme. These mutations cause the misfolding and dysfunction of IDUA, which leads to the toxic buildup of large sugars in the bone, cartilage, cornea, heart and central nervous system (CNS). There is currently no cure for these ...
-
Manufactured by NeuroMetrix, Inc.based in USA
Our Quell® Fibromyalgia device is an advanced wearable neuromodulator. It is the first and only FDA authorized medical device that helps reduce the symptoms of fibromyalgia. Quell Fibromyalgia is a thin wearable medical device that is inserted into a soft band, a disposable electrode is attached and then the band is placed on the upper calf. It is easy to use, wear and forget technology. The ...
-
based in AUSTRALIA
AdAlta is utilising the power of the i-body technology platform to develop a growing pipeline of i-bodies to treat a range of conditions, with an initial focus on treating fibrotic diseases. AdAlta identified an i-body that binds to the drug target, CXCR4 and demonstrates anti-fibrotic effects in several models of fibrosis. This was initially called AD-114. Following further development, AdAlta ...
-
Manufactured by BiomXbased in ISRAEL
BX003 is an orally administered phage cocktail targeting a bacterial target present in the gut of IBD and PSC patients and thought to be associated with the onset or exacerbation of these diseases. Although different organs are affected in IBD and PSC (gut in IBD and liver in PSC) the two diseases are thought to be related since approximately 70% of PSC patients also suffer from IBD. Results from ...
-
Manufactured by PRN Pharmacalbased in USA
The most commonly reported side effects were vomiting, loss of appetite, diarrhea, excessive salivation, agitation, tiredness, vocalization, confusion, increased water consumption, weight loss, weakness, fever, panting, and reversible changes in skin color (flushing or bright pink). Abnormal gait, seizures or tremors, as well as liver enzyme elevations, kidney failure, blood in urine and urine ...
-
based in UNITED KINGDOM
Many of the childhood-onset intractable epilepsy conditions within the expanded access program share considerable overlap with ASD and these conditions often fall within the orphan disease space. Initial clinical observations from treating physicians suggest a potential role for cannabinoids in addressing problems associated with ASD such as deficits in cognition, behavior, and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you